One of the most common frustrations I hear about TMS is the schedule. Conventional TMS for depression works — but it asks a lot: a session almost every weekday for four to six weeks, often 20 to 36 visits in all. For someone holding down a job, travelling from another city, or simply exhausted by their depression, six weeks of daily visits can feel like a wall.

So it's no surprise that "accelerated TMS," "SAINT," and even "one-day TMS" have become some of the questions patients ask me most. The promise is striking: the same treatment, compressed from weeks into days — or, some clinics now claim, a single day.

This article explains what accelerated TMS actually is, what the SAINT and 5-day protocols involve, where one-day treatment stands today, and — importantly — what the evidence really supports versus what is still early and unproven. My aim is to help you understand the options clearly, without hype.

First, what "accelerated" actually means

Standard TMS delivers one session per day. Accelerated TMS simply delivers several sessions per day — anywhere from two to ten — so the full number of treatments is completed in far less calendar time. The brain stimulation itself is the same tool: gentle magnetic pulses to a specific region involved in mood regulation. What changes is the schedule, not the fundamental mechanism.

That's the whole idea in one line: accelerated TMS packs more sessions into each day so the course finishes in days rather than weeks. The interesting — and sometimes overstated — questions are how well that works, and how far you can compress it.

The baseline: conventional once-daily TMSIt helps to anchor on the standard first. Conventional TMS is one session a day, five days a week, over roughly four to six weeks. It's well-established, FDA-approved, widely available, and has years of real-world safety behind it. Its main downsides are exactly the ones patients raise: the time commitment and the weeks of daily travel.

Everything "accelerated" is essentially an attempt to keep the benefits of TMS while shrinking that calendar.

The 5-day protocol: SAINT / SNTThe best-known accelerated protocol is SAINT — Stanford Accelerated Intelligent Neuromodulation Therapy, later called SNT (Stanford Neuromodulation Therapy). It compresses treatment into five consecutive days, with about ten short theta-burst sessions per day, spaced roughly an hour apart, at a higher overall dose than standard TMS.

The early results drew enormous attention. In the first open-label study of around 20 patients with treatment-resistant depression, close to 90% reached remission — a remarkable number for people who hadn't responded to other treatments. A subsequent double-blind, sham-controlled trial (the gold-standard design) confirmed that the real treatment clearly outperformed a sham: roughly a 52% reduction in depression scores versus about 11% with the placebo procedure. On the strength of this, an accelerated SAINT-style protocol received FDA clearance in 2022.

Here is the honest nuance that often gets lost in the headlines. The SAINT studies didn't only compress the schedule — they also used individual brain imaging (fMRI) to pinpoint each person's precise stimulation target. That imaging-guided targeting is part of why the numbers were so high, and it makes the research protocol expensive and hard to reproduce everywhere. So the striking "90% remission" figure belongs specifically to the imaging-guided research version, in small early samples. It's genuinely promising — but it shouldn't be read as a guarantee, or assumed automatically for every "accelerated TMS" a clinic advertises.

Encouragingly, the field is now clarifying that accelerated schedules can also be delivered using well-established scalp-based targeting methods, without the MRI step — and in 2026 regulators expanded clearance for accelerated protocols to be used with or without that imaging. That matters a great deal for access, because MRI-guided targeting for every patient simply isn't practical or affordable in most clinics, in India or elsewhere. The reasonable, honest position is this: accelerated TMS with standard targeting is a legitimate, evidence-supported option — just not identical to, and not guaranteed to match, the headline SAINT research numbers.

One-day protocol: the newest frontier

If five days sounds fast, you may have seen clinics advertising single-day or "one-day" TMS — delivering a whole compressed course within one day. The idea is appealing, especially for someone travelling a long way or in urgent distress. But the published evidence for one-day protocols is very early — small, preliminary studies rather than the larger, replicated, sham-controlled trials we'd want before calling something established. We don't yet have strong data on how durable a single day of treatment is, who it suits best, or how it truly compares to the 5-day or standard schedules over time.That doesn't make it worthless — early neuromodulation research is exactly how SAINT itself began. If a clinic offers it, the right questions are: what evidence is this based on, what are realistic expectations, and what's the plan if a single day isn't enough? 

So is faster better?

Not automatically — and that's the key point. Compressing the schedule mainly changes convenience and speed of access, which are real and meaningful benefits. What it doesn't do is guarantee a better or longer-lasting result than standard TMS for every person.

Where accelerated protocols are genuinely attractive:

  • Time and travel. For someone who can't commit to six weeks of daily visits — because of work, distance, or caregiving — completing treatment in days can be the difference between getting care and getting none.
  • Urgency. When depression is severe and time matters, a faster course is appealing.
  • Access. Now that accelerated schedules can be delivered without expensive imaging, more clinics can realistically offer them.
  • Cost. Cheaper than the regular 4-6 week protocols

Where honest caution belongs:

The strongest accelerated evidence (SAINT) comes from small studies using imaging-guided targeting — impressive, but not the same as a large, routine, real-world guarantee.

One-day protocols are early-stage. Treat bold claims with healthy skepticism.

Like all TMS, benefits can fade over time for some people, so a plan for maintenance or follow-up matters regardless of how fast the initial course was.

Who is accelerated TMS actually for?

Accelerated TMS is generally considered in the same situations as standard TMS — most often treatment-resistant depression, where one or more antidepressants haven't given enough relief — with the added appeal for people who cannot manage a weeks-long daily schedule.

It is usually not the first step for milder depression, or for someone who hasn't yet properly tried standard, well-evidenced first-line treatments like therapy and an adequately-dosed antidepressant. And it isn't right for everyone: a proper psychiatric assessment is needed first, to confirm the diagnosis, rule out contraindications (such as certain implanted devices or a seizure history), and decide whether the accelerated schedule genuinely fits your situation — rather than fitting you to a marketing package.

The most important thing I tell patients is that the schedule is a convenience decision, while whether TMS is right for you at all is a clinical one. Those are two separate questions, and the second matters more.

Questions worth asking any clinic 

If you're considering accelerated, SAINT-style, or one-day TMS, these questions will tell you a lot:

  • Which protocol is it, and how many sessions per day and over how many days?
  • How is my stimulation target chosen — standard scalp-based methods or imaging-guided? (Both can be appropriate; the point is that they're honest about it.)
  • What evidence is this specific protocol based on, especially for one-day treatment?
  • What are realistic expectations, and what's the plan if the first course isn't enough?
  • Who assesses me first, and who oversees the treatment?

A good clinic will welcome these questions and answer them plainly. Vague promises of a fast "cure" are the red flag.

The honest summary

Accelerated TMS is a genuine and exciting evolution of an established treatment: by delivering several sessions a day, it can compress weeks of TMS into days. The 5-day SAINT protocol produced striking early results and is FDA-cleared. One-day protocols are newer still and remain early but have shown promising results.

For the right person — particularly someone with treatment-resistant depression who can't manage six weeks of daily visits — accelerated TMS can be a real, practical, evidence-based option, and the fact that it no longer requires expensive imaging is genuinely good news for access. But faster isn't automatically better, and the decision about whether TMS suits you is best made through a careful clinical assessment, not a headline or a countdown.